Code | 09505 | ||||||||||
MA number | EU/1/11/700/002 | ||||||||||
Product Form: | plc ifc 1x400 mg (liek.inj.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | GlaxoSmithKline (Ireland) Limited, Ireland | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 60 | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 13.07.2011 |
SmPC + PL: |
|
Dokument: |
|
Safety feature | Yes |
Data update: | 15.06.2018 |